Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

SHA:600572 Revenue

Zhejiang CONBA Pharmaceutical had revenue of 1.68B CNY in the quarter ending March 31, 2025, a decrease of -7.64%. This brings the company's revenue in the last twelve months to 6.38B, down -0.79% year-over-year. In the year 2024, Zhejiang CONBA Pharmaceutical had annual revenue of 6.52B, down -3.23%.

• Revenue (ttm): 6.38B
• Revenue Growth: -0.79%
• P/S Ratio: 1.75
• Revenue / Employee: 758.02K
• Employees: 8,411
• Market Cap: 11.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.52B	-217.63M	-3.23%
Dec 31, 2023	6.73B	732.35M	12.20%
Dec 31, 2022	6.00B	-567.74M	-8.64%
Dec 31, 2021	6.57B	659.17M	11.16%
Dec 31, 2020	5.91B	-859.28M	-12.70%